FRIDAY, Nov. 22, 2024 (HealthDay News) -- An estimated 100,429 youth are living with pediatric inflammatory bowel disease (PIBD) in the United States, according to a research letter published online Nov. 20 in Gastroenterology.
Michael D. Kappelman, M.D., M.P.H., from the University of North Carolina at Chapel Hill, and colleagues analyzed two commercial insurance claims datasets along with data from five state Medicaid plans to describe the prevalence of PIBD among individuals younger than 20 years.
The researchers found that the age-, sex-, and insurance status-standardized prevalence per 100,000 population was 122 for IBD, 71 for Crohn disease (CD), and 44 for ulcerative colitis (UC). Based on a 2020 U.S. census population, an estimated 100,429 American youth are living with IBD, including 58,733 with CD and 36,270 with UC. All prevalence rates increased with age. The prevalence of CD was higher in males than females. There was variation observed in prevalence by race and ethnicity, with prevalence rates of 145, 91, 52, and 88 per 100,00 population in White, Black, Asian, and Hispanic Americans, respectively. Over time, there was a slight increase seen in PIBD, from 110 per 100,000 in 2011 to 119, 126, and 125 per 100,000 in 2014, 2017, and 2020, respectively.
"These data are essential for health care professionals and policymakers to effectively manage pediatric IBD, make informed public health decisions, and ultimately improve outcomes for affected children and adolescents," Andrés Hurtado-Lorenzo, Ph.D., senior vice president of translational research and IBD ventures at the Crohn's & Colitis Foundation and study co-author, said in a statement.
Two authors disclosed ties to the biopharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
